149 related articles for article (PubMed ID: 24820303)
1. [Ultrasound soft markers and fetal cardiac structural assessment at 11-14 weeks].
Yang Y; Zhang Y
Zhonghua Fu Chan Ke Za Zhi; 2014 Mar; 49(3):188-92. PubMed ID: 24820303
[TBL] [Abstract][Full Text] [Related]
2. Prenatal detection of congenital heart disease at 12-13 gestational weeks: detailed analysis of false-negative cases.
Bottelli L; Franzè V; Tuo G; Buffelli F; Paladini D
Ultrasound Obstet Gynecol; 2023 May; 61(5):577-586. PubMed ID: 36240512
[TBL] [Abstract][Full Text] [Related]
3. The diagnostic performance of the ductus venosus for the detection of cardiac defects in the first trimester: a systematic review and diagnostic test accuracy meta-analysis.
Savoia F; Scala C; Coppola M; Riemma G; Vitale SG; Mikuš M; Schiattarella A; La Verde M; Colacurci N; De Franciscis P; Morlando M
Arch Gynecol Obstet; 2023 Aug; 308(2):435-451. PubMed ID: 36315269
[TBL] [Abstract][Full Text] [Related]
4. First Trimester Tricuspid Regurgitation: Clinical Significance.
Teixeira S; Guedes-Martins L
Curr Cardiol Rev; 2023; 19(3):e061222211643. PubMed ID: 36475342
[TBL] [Abstract][Full Text] [Related]
5. First trimester screening for major cardiac defects based on the ductus venosus flow in fetuses with trisomy 21.
Wagner P; Sonek J; Eberle K; Abele H; Hoopmann M; Prodan N; Kagan KO
Prenat Diagn; 2018 Apr; ():. PubMed ID: 29663466
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic yield of copy number variation sequencing in fetuses with increased nuchal translucency: a retrospective study.
Yang X; Bian X; Shi X; Ding J; Tang H; Xu P; Deng D; Zeng W; Chen S; Qiao F; Feng L; Wu Y
Arch Gynecol Obstet; 2024 Jan; 309(1):139-144. PubMed ID: 36602560
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of atrioventricular valve regurgitation in the first trimester for the diagnosis of atrioventricular septal defect.
Yang S; Liang M; Qin G; Tang Y; Liang Y; Pang Y; Yang Z
J Clin Ultrasound; 2024 May; 52(4):405-414. PubMed ID: 38362713
[TBL] [Abstract][Full Text] [Related]
8. Elevated nuchal translucency, is it time to discuss the cut off?
Pasquini L; Ponziani I; Spataro E; Masini G; Biancareddu E; Cordisco A; Petraglia F
Int J Gynaecol Obstet; 2023 Nov; 163(2):540-546. PubMed ID: 37128959
[TBL] [Abstract][Full Text] [Related]
9. Different Cutoff Values for Increased Nuchal Translucency in First-Trimester Screening to Predict Fetal Chromosomal Abnormalities.
Su L; Wu X; Lin N; Xie X; Cai M; Wang M; Zheng L; Xu L
Int J Gen Med; 2021; 14():8437-8443. PubMed ID: 34819751
[TBL] [Abstract][Full Text] [Related]
10. Deep-learning computer vision can identify increased nuchal translucency in the first trimester of pregnancy.
Kasera B; Shinar S; Edke P; Pruthi V; Goldenberg A; Erdman L; Van Mieghem T
Prenat Diagn; 2024 May; 44(5):535-543. PubMed ID: 38558081
[TBL] [Abstract][Full Text] [Related]
11. Fetal Intelligent Navigation Echocardiography (FINE) Detects 98% of Congenital Heart Disease.
Yeo L; Luewan S; Romero R
J Ultrasound Med; 2018 Nov; 37(11):2577-2593. PubMed ID: 29603310
[TBL] [Abstract][Full Text] [Related]
12. The value of combined detailed first-trimester ultrasound-biochemical analysis for screening fetal aneuploidy in the era of non-invasive prenatal testing.
Ye C; Duan H; Liu M; Liu J; Xiang J; Yin Y; Zhou Q; Yang D; Yan R; Li R
Arch Gynecol Obstet; 2023 Nov; ():. PubMed ID: 37938359
[TBL] [Abstract][Full Text] [Related]
13. First trimester screening using ultrasound and serum markers in Panamanians: Factors associated with adverse pregnancy outcomes.
Herrera TT; Sinisterra S; Solis A; Britton GB
J Res Med Sci; 2014 May; 19(5):451-6. PubMed ID: 25097629
[TBL] [Abstract][Full Text] [Related]
14. Early Detection of Isolated Severe Congenital Heart Defects Is Associated with a Lower Threshold to Terminate the Pregnancy.
Lugthart MA; Verbaarschot E; van Nisselrooij AEL; van de Kamp K; Kleinrouweler E; Haak MC; Rozendaal L; Linskens I; Hruda J; Snijders RJM; van Leeuwen E; Clur SA; Pajkrt E
Fetal Diagn Ther; 2023; 50(4):248-258. PubMed ID: 37331329
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic Value of Fetal Echocardiography for Congenital Heart Disease: A Systematic Review and Meta-Analysis.
Zhang YF; Zeng XL; Zhao EF; Lu HW
Medicine (Baltimore); 2015 Oct; 94(42):e1759. PubMed ID: 26496297
[TBL] [Abstract][Full Text] [Related]
16. Clinical value of screening prenatal ultrasound combined with chromosomal microarrays in prenatal diagnosis of chromosomal abnormalities.
Jiang H; Kong X; Bian W; Liu J; Xu Y; Cui A; Cao X
J Matern Fetal Neonatal Med; 2024 Dec; 37(1):2324348. PubMed ID: 38466173
[TBL] [Abstract][Full Text] [Related]
17. Deep-learning model for prenatal congenital heart disease screening generalizes to community setting and outperforms clinical detection.
Athalye C; van Nisselrooij A; Rizvi S; Haak MC; Moon-Grady AJ; Arnaout R
Ultrasound Obstet Gynecol; 2024 Jan; 63(1):44-52. PubMed ID: 37774040
[TBL] [Abstract][Full Text] [Related]
18. The associations of nuchal translucency and fetal abnormalities; significance and implications.
Salman Guraya S
J Clin Diagn Res; 2013 May; 7(5):936-41. PubMed ID: 23814750
[TBL] [Abstract][Full Text] [Related]
19. The Use of Ultrasound as a Potential Adjunct to Cell-Free Fetal DNA Screening for Aneuploidy at Weill Cornell Medical College, New York, USA.
Scholl J; Chasen S
Surg J (N Y); 2018 Jan; 4(1):e1-e6. PubMed ID: 29435489
[No Abstract] [Full Text] [Related]
20. Prenatal diagnosis and perinatal outcomes of twin pregnancies disharmonious for one fetus with nuchal translucency above the 95th percentile.
Wang Y; Zhou H; Fu F; Cheng K; Huang R; Li R; Li D; Liao C
Mol Cytogenet; 2023 Nov; 16(1):30. PubMed ID: 37908008
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
